"If we are able to enhance public and private collaboration it can on the one hand lead to more jobs and new industries, and on the other enrich the academic basic research" explains Dr. Per Spindler, Director of BioLogue / Danish Pharma Consortium. "Medicon Valley has the potential to be globally competitive within Biosystems technology" he adds.
The region already counts several world class research environments within the field. "In the case of bioinformatics and systems biology we try to network top-notch environments in academia and industry", says Dr. Thomas Schou, Head of Secretariat, BioSys Knowledge Network.
The EU funded project Boost Biosystems boosts research collaborations between companies and academia within biosystems technologies. ScanBalt, BioLogue and BioSys have arranged an executive roundtable with selected representatives from academia, industry and the support organisations from the Medicon Valley region to facilitat, strengthen and promote these collaborations.
The Executive Roundtable Discussion "Enabling private-public partnership in Biosystem technologies in Medicon Valley" will take place on 6 December 2007 at Carlsberg Akademi in Copenhagen. In the international context, the lack of interaction between players impedes the introduction of innovative Biosystems technologies to the sectors they could serve. By mobilizing actors in the Medicon Valley Region, this executive roundtable will provide an opportunity to create a platform for knowledge transfer, collaboration and common strategy for public-private partnerships in this new technology field.
The biosystems field has major focus in EU FP7 programms, reflected by several new funding opportunities. During the executive roundtable, these opportunities will be briefly presented and the benefits for the Medicon Valley region outlined. The outcome of the executive roundtable will be published as a white paper with an executive summary.
Biosystems technology is a cross-disciplinary field including several sub-disciplines within biotechnology, biomedicine, bioinformatics and microsystems technology. Biosystems focus on both technical (e.g. diagnostics, in vitro tests, pharmacogenomics and postgenomic applications) as well as disease related aspects. Improvements in biosystems technologies target unanswered questions in the diagnosis and therapy of major diseases (cardiovascular diseases, diabetes, neurodegenerations, aging related disorders, cancer).
Peter Frank | idw
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences